Literature DB >> 16625844

Diagnosis and treatment of acromegaly and its complications: consensus guidelines.

S Bonadonna1, M Doga, M Gola, G Mazziotti, A Giustina.   

Abstract

In February 1999, May 2000 and April 2002, three workshops were held in Cortina, Montecarlo and Versailles, respectively, to develop a consensus defining the diagnosis and treatment of acromegaly and its complications. The workshops were sponsored by the Pituitary Society and European Neuroendocrine Association. Invited international participants included endocrinologists, neurosurgeons and radiotherapists skilled in the management of acromegaly. This review paper summarizes the main points of the three consensus statements published following these three workshops.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16625844

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  3 in total

1.  Insight into cardiovascular risk factors in patients with acromegaly.

Authors:  Maria Fleseriu
Journal:  Endocrine       Date:  2014-01-11       Impact factor: 3.633

Review 2.  Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.

Authors:  Monica Gola; Mauro Doga; Stefania Bonadonna; Gherardo Mazziotti; Pier Paolo Vescovi; Andrea Giustina
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 3.  Medical therapy of acromegaly: efficacy and safety of somatostatin analogues.

Authors:  Richard A Feelders; Leo J Hofland; Maarten O van Aken; Sebastian J Neggers; Steven W J Lamberts; Wouter W de Herder; Aart-Jan van der Lely
Journal:  Drugs       Date:  2009-11-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.